Newsfeeds - Spark Newswire

4 minute read

InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday

Today, 11:24 AM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

ACIU

3 minute read

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 11:24 AM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

AGRX

1 minute read

News

ENDRA Life Sciences Enhances TAEUS System Intellectual Property Portfolio With Issuance Of 28th U.S. Patent

By Benzinga Newsdesk

Today, 11:24 AM

ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272

NDRA

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 11:24 AM

Gainers Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion.

ABIO

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 11:24 AM

Gainers Sana Biotechnology (NASDAQ:SANA) shares moved upwards by 9.1% to $6.1 during Friday's after-market session. The company's market cap stands at $1.1 billion.

AIKI

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 11:24 AM

ATNF

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 11:24 AM

Gainers

ACOR

1 minute read

ENDRA Life Sciences Reports In Form4 Filing Director Alexander Tokman Buys 100K Shares At Average Price Of $0.20/Share

By Benzinga Newsdesk

Today, 11:24 AM

-SEC Filing

NDRA

1 minute read

ENDRA Life Sciences Q1 EPS $(0.07), Inline

By Benzinga Newsdesk

Today, 11:24 AM

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

NDRA

1 minute read

Earnings

ENDRA Life Sciences: Q1 Earnings Insights

By Benzinga Insights

Today, 11:24 AM

ENDRA Life Sciences (NASDAQ:NDRA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ENDRA Life Sciences reported in-line EPS of $-0.07 versus an estimate of $-0.07.

NDRA